Layerbio, Inc

CBSET Inc is a leading preclinical science company based in Lexington, MA, offering innovative solutions for medical device testing, drug cell-based therapies, histopathology morphometry, and education training. With a unique integrated approach, CBSET combines in vivo testing, detailed histopathological analysis, and computational modeling to address complex scientific questions and improve regulatory efficiency. CBSET's specialized expertise lies in the pre-clinical evaluation and development of novel diagnostic and therapeutic medical devices, as well as the evaluation of pharmacology, toxicity, and biodistribution of drugs and cell-based therapeutics. Their commitment to education extends from sharing groundbreaking data with the scientific community to training physicians on new procedures and techniques, making CBSET a trusted partner in advancing medical innovation and improving lives.Generated from the website

MedChem Partners is a specialty research and discovery organization based in Lexington, MA, focused on providing chemistry support for early and mid-stage drug discovery programs. Established in 2006, the company offers a range of services including medicinal chemistry, custom synthesis, and analytical support, effectively acting as an in-house chemistry department for clients. Recognized for its agility in handling high-risk projects with changing priorities, MedChem Partners emphasizes quick turnaround times and tailored project management to conserve client resources. Their expertise extends to specialty chemistry, including nitric oxide and lipid chemistry, as well as serving as expert witnesses in chemistry-related legal cases. Generated from the website

SaponiQx Inc. is a biopharmaceutical company based in Lexington, MA, dedicated to enhancing global health through the development of safe and effective vaccines. The company specializes in saponin-based adjuvants, particularly its proprietary product, STIMULON QS21, which is a key component in the FDA-approved Shingrix vaccine by GSK. With a focus on improving vaccine efficacy, extending protection, and reducing costs, SaponiQx aims to make critical adjuvants widely available for life-saving vaccines. Their innovative manufacturing process allows for sustainable production of QS21 at commercial scale, replacing traditional methods that rely on limited natural resources. Generated from the website